Sarepta shareholders approve 2026 equity plans; elect directors at annual meeting

Proposal 1: Election of Directors The director nominees listed below were elected to serve on the Company’s board of directors as members of Class I for a term of two years. The results of the vote were as follows: Name of Nominee For Against Abstain Broker Non-Votes Douglas S. Ingram 66,812,593 827,973 52,441 14,616,281 Hans Wigzell, M.D., Ph.D. 56,984,756 10,663,180 45,071 14,616,281 Kathryn J. Boor, Ph.D. 63,915,239 3,722,626 55,142 14,616,281 Michael Chambers 65,892,431 1,752,077 48,499 14,616,281 Deirdre Connelly 53,419,881 14,213,242 59,884 14,616,281

Proposal 3: Approval of the Company ’s 2026 Equity Incentive Plan The stockholders approved the 2026 Plan. The results of the vote were as follows: For Against Abstain Broker Non-Votes 63,233,193 4,395,283 64,531 14,616,281

Proposal 5: Ratification of KPMG as the Company ’s Independent Registered Public Accounting Firm The stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the current year ending December 31, 2026. The results of the vote were as follows: For Against Abstain 79,907,368 2,110,136 291,784

Proposal 2: Advisory Vote to Approve Named Executive Officer Compensation The stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers for 2025. The results of the advisory vote were as follows: For Against Abstain Broker Non-Votes 45,185,398 22,373,065 134,544 14,616,281

Proposal 4: Approval of the Company ’s 2026 Employee Stock Purchase Plan The stockholders approved the 2026 ESPP. The results of the vote were as follows: For Against Abstain Broker Non-Votes 67,098,699 532,525 61,783 14,616,281